Chagasic patients are able to respond against a viral antigen from influenza virus.

PubWeight™: 0.76‹?›

🔗 View Article (PMC 3511223)

Published in BMC Infect Dis on August 24, 2012

Authors

Paola Lasso1, Diana Mesa, Natalia Bolaños, Adriana Cuéllar, Fanny Guzmán, Zulma Cucunuba, Fernando Rosas, Víctor Velasco, Maria C Thomas, Manuel Carlos López, John Mario González, Concepción Judith Puerta

Author Affiliations

1: Laboratorio de Parasitología Molecular, Pontificia Universidad Javeriana, Bogotá, Colombia.

Articles cited by this

Central memory and effector memory T cell subsets: function, generation, and maintenance. Annu Rev Immunol (2004) 17.54

Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major. Nat Med (2007) 11.80

Chagas disease. Lancet (2010) 10.25

Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections. Nat Med (2002) 10.03

ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). J Am Coll Cardiol (2005) 6.77

Memory CD8 T-cell differentiation during viral infection. J Virol (2004) 6.75

Phototyping: comprehensive DNA typing for HLA-A, B, C, DRB1, DRB3, DRB4, DRB5 & DQB1 by PCR with 144 primer mixes utilizing sequence-specific primers (PCR-SSP). Tissue Antigens (1995) 6.33

HIV-specific CD8(+) T cells produce antiviral cytokines but are impaired in cytolytic function. J Exp Med (2000) 5.79

Evaluation and treatment of chagas disease in the United States: a systematic review. JAMA (2007) 5.22

Clinical and epidemiological aspects of Chagas disease. Lancet Infect Dis (2001) 4.13

CD8 T cell dysfunction during chronic viral infection. Curr Opin Immunol (2007) 3.87

Original antigenic sin impairs cytotoxic T lymphocyte responses to viruses bearing variant epitopes. Nature (1998) 3.78

Chagas disease: a Latin American health problem becoming a world health problem. Acta Trop (2009) 3.57

Partial purification and some properties of BB7.2. A cytotoxic monoclonal antibody with specificity for HLA-A2 and a variant of HLA-A28. Hum Immunol (1981) 3.01

Pathophysiology of the heart in Chagas' disease: current status and new developments. Cardiovasc Res (2003) 1.97

The minimum peptide epitope from the influenza virus matrix protein. Extra and intracellular loading of HLA-A2. J Immunol (1991) 1.96

CD8+ T-Cell responses to Trypanosoma cruzi are highly focused on strain-variant trans-sialidase epitopes. PLoS Pathog (2006) 1.93

Frequency of interferon- gamma -producing T cells specific for Trypanosoma cruzi inversely correlates with disease severity in chronic human Chagas disease. J Infect Dis (2004) 1.79

Genetic polymorphism within HLA-A*02: significant allelic variation revealed in different populations. Tissue Antigens (1995) 1.70

Harmonization guidelines for HLA-peptide multimer assays derived from results of a large scale international proficiency panel of the Cancer Vaccine Consortium. Cancer Immunol Immunother (2009) 1.63

Immunobiology of murine T. cruzi infection: the predominance of parasite-nonspecific responses and the activation of TCRI T cells. Immunol Rev (1989) 1.53

Trypanosoma cruzi modulates the profile of memory CD8+ T cells in chronic Chagas' disease patients. Int Immunol (2006) 1.51

Pathogenesis of chagas' disease: parasite persistence and autoimmunity. Clin Microbiol Rev (2011) 1.38

Depletion of T-cell subpopulations results in exacerbation of myocarditis and parasitism in experimental Chagas' disease. Infect Immun (1994) 1.38

Generation, specificity, and function of CD8+ T cells in Trypanosoma cruzi infection. Immunol Rev (2004) 1.36

HLA Class I-T cell epitopes from trans-sialidase proteins reveal functionally distinct subsets of CD8+ T cells in chronic Chagas disease. PLoS Negl Trop Dis (2008) 1.19

Insufficient TLR activation contributes to the slow development of CD8+ T cell responses in Trypanosoma cruzi infection. J Immunol (2009) 1.17

Infection with Trypanosoma cruzi restricts the repertoire of parasite-specific CD8+ T cells leading to immunodominance. J Immunol (2008) 1.15

Travel and migration associated infectious diseases morbidity in Europe, 2008. BMC Infect Dis (2010) 1.14

Concerted action of perforin and granzymes is critical for the elimination of Trypanosoma cruzi from mouse tissues, but prevention of early host death is in addition dependent on the FasL/Fas pathway. Eur J Immunol (2003) 1.07

Human CD8+ T cells specific for influenza A virus M1 display broad expression of maturation-associated phenotypic markers and chemokine receptors. Immunology (2005) 1.04

Cutting edge: dysfunctional CD8+ T cells reside in nonlymphoid tissues during chronic Trypanosoma cruzi infection. J Immunol (2003) 1.02

Inducible cyclooxygenase released prostaglandin mediates immunosuppression in acute phase of experimental Trypanosoma cruzi infection. Exp Parasitol (2005) 0.97

Identification of multiple HLA-A*0201-restricted cruzipain and FL-160 CD8+ epitopes recognized by T cells from chronically Trypanosoma cruzi-infected patients. Microbes Infect (2005) 0.96

Chagas disease (American trypanosomiasis) fact sheet (revised in June 2010). Wkly Epidemiol Rec (2010) 0.95

Maternal infection with Trypanosoma cruzi and congenital Chagas disease induce a trend to a type 1 polarization of infant immune responses to vaccines. PLoS Negl Trop Dis (2009) 0.90

Trypanosoma cruzi induces regulatory dendritic cells in vitro. Infect Immun (2008) 0.88

Frequency of specific CD8+ T cells for a promiscuous epitope derived from Trypanosoma cruzi KMP-11 protein in chagasic patients. Parasite Immunol (2010) 0.87

Evaluation of IFN-gamma production by CD8 T lymphocytes in response to the K1 peptide from KMP-11 protein in patients infected with Trypanosoma cruzi. Parasite Immunol (2006) 0.86

Peptide-based analysis of the amino acid sequence important to the immunoregulatory function of Trypanosoma cruzi Tc52 virulence factor. Immunology (2003) 0.84

Identification of HLA-A∗02:01-restricted CTL epitopes in Trypanosoma cruzi heat shock protein-70 recognized by Chagas disease patients. Microbes Infect (2011) 0.80

Synthesis, isolation and characterization of Plasmodium falciparum antigenic tetrabranched peptide dendrimers obtained by thiazolidine linkages. J Pept Res (2001) 0.80

Identification of HLA-A*0201-restricted cytotoxic T-cell epitopes of Trypanosoma cruzi TcP2beta protein in HLA-transgenic mice and patients. Microbes Infect (2003) 0.77

Articles by these authors

Randomized Trial of Benznidazole for Chronic Chagas' Cardiomyopathy. N Engl J Med (2015) 5.31

Rationale and design of a randomized placebo-controlled trial assessing the effects of etiologic treatment in Chagas' cardiomyopathy: the BENznidazole Evaluation For Interrupting Trypanosomiasis (BENEFIT). Am Heart J (2008) 1.99

Utility of the NavX® Electroanatomic Mapping System for Permanent Pacemaker Implantation in a Pregnant Patient with Chagas Disease. Indian Pacing Electrophysiol J (2013) 1.40

Toward the assessment of food toxicity for celiac patients: characterization of monoclonal antibodies to a main immunogenic gluten peptide. PLoS One (2008) 1.32

Sensitive detection of cereal fractions that are toxic to celiac disease patients by using monoclonal antibodies to a main immunogenic wheat peptide. Am J Clin Nutr (2008) 1.30

Chagas cardiomyopathy manifestations and Trypanosoma cruzi genotypes circulating in chronic Chagasic patients. PLoS Negl Trop Dis (2010) 1.26

Contemporary cryptic sexuality in Trypanosoma cruzi. Mol Ecol (2012) 1.21

Evaluation of adult chronic Chagas' heart disease diagnosis by molecular and serological methods. J Clin Microbiol (2009) 1.17

The costs of preventing and treating chagas disease in Colombia. PLoS Negl Trop Dis (2008) 1.14

Plasmodium vivax promiscuous T-helper epitopes defined and evaluated as linear peptide chimera immunogens. Infect Immun (2002) 1.00

Evaluating Chagas disease progression and cure through blood-derived biomarkers: a systematic review. Expert Rev Anti Infect Ther (2013) 0.90

Immunogenicity of HSP-70, KMP-11 and PFR-2 leishmanial antigens in the experimental model of canine visceral leishmaniasis. Vaccine (2008) 0.89

Expression, polymorphism analysis, reticulocyte binding and serological reactivity of two Plasmodium vivax MSP-1 protein recombinant fragments. Vaccine (2003) 0.86

Detection of Trypanosoma cruzi and Trypanosoma rangeli infection in triatomine vectors by amplification of the histone H2A/SIRE and the sno-RNA-C11 genes. Rev Inst Med Trop Sao Paulo (2007) 0.86

Long-term effects of habitat fragmentation on mating patterns and gene flow of a tropical dry forest tree, Ceiba aesculifolia (Malvaceae: Bombacoideae). Am J Bot (2013) 0.86

Increased CD4+/CD8+ double-positive T cells in chronic Chagasic patients. PLoS Negl Trop Dis (2011) 0.85

[Acute Chagas disease in Colombia: a rarely suspected disease. Report of 10 cases presented during the 2002-2005 period]. Biomedica (2007) 0.85

A novel antifungal peptide designed from the primary structure of a natural antimicrobial peptide purified from Argopecten purpuratus hemocytes. Peptides (2009) 0.84

Identification of HLA-A2 restricted CD8(+) T-lymphocyte responses to Plasmodium vivax circumsporozoite protein in individuals naturally exposed to malaria. Parasite Immunol (2002) 0.84

Microbial heat shock protein 70 stimulatory properties have different TLR requirements. Vaccine (2006) 0.83

Trypanosoma cruzi paraflagellar rod proteins 2 and 3 contain immunodominant CD8(+) T-cell epitopes that are recognized by cytotoxic T cells from Chagas disease patients. Mol Immunol (2012) 0.83

Characterising the KMP-11 and HSP-70 recombinant antigens' humoral immune response profile in chagasic patients. BMC Infect Dis (2009) 0.82

Anti-glucuronoxylomannan IgG1 specific antibodies production in Cryptococcus neoformans resistant mice. Biomedica (2005) 0.81

Monocyte-derived dendritic cells from chagasic patients vs healthy donors secrete differential levels of IL-10 and IL-12 when stimulated with a protein fragment of Trypanosoma cruzi heat-shock protein-70. Immunol Cell Biol (2008) 0.81

T lymphocytes from chagasic patients are activated but lack proliferative capacity and down-regulate CD28 and CD3ζ. PLoS Negl Trop Dis (2013) 0.81

[Using S35-S36 and TcH2AF-R primer-based PCR tests to follow-up a Chagas´ disease patient who had undergone a heart transplant]. Biomedica (2011) 0.80

Natural CD4(+) T-cell responses against Trypanosoma cruzi KMP-11 protein in chronic chagasic patients. Immunol Cell Biol (2008) 0.80

Identification of HLA-A∗02:01-restricted CTL epitopes in Trypanosoma cruzi heat shock protein-70 recognized by Chagas disease patients. Microbes Infect (2011) 0.80

Mapping the anatomy of a Plasmodium falciparum MSP-1 epitope using pseudopeptide-induced mono- and polyclonal antibodies and CD and NMR conformation analysis. J Struct Biol (2004) 0.79

[Myotonic dystrophy and bundle-branch re-entrant tachycardia]. Rev Esp Cardiol (2002) 0.79

BTM-P1 polycationic peptide biological activity and 3D-dimensional structure. Biochem Biophys Res Commun (2006) 0.79

An immunological method for quantifying antibacterial activity in Salmo salar (Linnaeus, 1758) skin mucus. Fish Shellfish Immunol (2009) 0.79

Characterization and functional recovery of a novel antimicrobial peptide (CECdir-CECret) from inclusion bodies after expression in Escherichia coli. Peptides (2008) 0.79

[Evaluation of TcH2AF-R and S35-S36 primers in PCR tests for the detection of Trypanosoma cruzi in mouse cardiac tissue]. Biomedica (2008) 0.79

Characterization of an immunodominant antigenic epitope from Trypanosoma cruzi as a biomarker of chronic Chagas' disease pathology. Clin Vaccine Immunol (2011) 0.79

Detection of the hepcidin prepropeptide and mature peptide in liver of rainbow trout. Dev Comp Immunol (2013) 0.79

A human astrocytoma cell line is highly susceptible to infection with Trypanosoma cruzi. Mem Inst Oswaldo Cruz (2013) 0.78

Design and activity of novel lactoferrampin analogues against O157:H7 enterohemorrhagic escherichia coli. Biopolymers (2014) 0.78

Complexes of D-type cyclins with CDKs during maize germination. J Exp Bot (2013) 0.78

MHC allele-specific binding of a malaria peptide makes it become promiscuous on fitting a glycine residue into pocket 6. Biochem Biophys Res Commun (2003) 0.78

Immunogenicity and protectivity of Plasmodium falciparum EBA-175 peptide and its analog is associated with alpha-helical region shortening and displacement. Biol Chem (2003) 0.78

Human papillomavirus type 16 and 18 L1 protein peptide binding to VERO and HeLa cells inhibits their VLPs binding. Int J Cancer (2003) 0.78

Development of a sandwich ELISA for quantifying hepcidin in Rainbow trout. Fish Shellfish Immunol (2013) 0.78

Analysis of a Plasmodium falciparum EBA-175 peptide with high binding capacity to erythrocytes and their analogues using 1H NMR. J Struct Biol (2003) 0.77

The Trypanosoma rangeli histone H2A gene sequence serves as a differential marker for KP1 strains. Infect Genet Evol (2006) 0.77

Immunogenicity of Sm32 synthetic peptides derived from the Schistosoma mansoni adult worm. Immunol Lett (2003) 0.77

Immune response in mice and cattle after immunization with a Boophilus microplus DNA vaccine containing bm86 gene. Vet Parasitol (2006) 0.77

Specific erythrocyte binding capacity and biological activity of Plasmodium falciparum-derived rhoptry-associated protein 1 peptides. Vaccine (2004) 0.77

Characterizing cellular immune response to kinetoplastid membrane protein-11 (KMP-11) during Leishmania (Viannia) panamensis infection using dendritic cells (DCs) as antigen presenting cells (APCs). Parasite Immunol (2003) 0.76

Response to Letter: "Use of Electroanatomic Mapping Systems beyond Electrophysiologic Studies". Indian Pacing Electrophysiol J (2013) 0.75

[Flow cytometry model for the detection of neutralizing antibodies against of IFN-β]. Biomedica (2013) 0.75

[Chromosomal localization of the KMP-11 genes in the KP1(+) and KP1(-) strains of Trypanosoma rangeli]. Biomedica (2004) 0.75

[Expression of markers on dendritic cells from chronic chagasic patients stimulated with the KMP-11 protein and the K1 peptide from Trypanosoma cruzi]. Biomedica (2007) 0.75

A natural peptide and its variants derived from the processing of infectious pancreatic necrosis virus (IPNV) displaying enhanced antimicrobial activity: a novel alternative for the control of bacterial diseases. Peptides (2011) 0.75

[The intergenic region of the histone H2a gene supports two major lineages of Trypanosoma rangeli]. Biomedica (2007) 0.75

Synthetic vaccine update: applying lessons learned from recent SPf66 malarial vaccine physicochemical, structural and immunological characterization. Vaccine (2007) 0.75

Plasmodium falciparum normocyte binding protein (PfNBP-1) peptides bind specifically to human erythrocytes. Peptides (2003) 0.75

[Expression of IL-10, IL-4 and IFN-γ in active skin lesions of children with papular urticaria]. Biomedica (2012) 0.75

[Phenotypical determinants of stem cell subpopulations derived from human umbilical cord blood]. Biomedica (2006) 0.75

Rabbit serum against K1 peptide, an immunogenic epitope of the Trypanosoma cruzi KMP-11, decreases parasite invasion to cells. Acta Trop (2012) 0.75

Differences in systemic and skin migrating-specific CD4 T cells in papular urticaria by flea bite. Int Arch Allergy Immunol (2012) 0.75

Serum biochemical analytes in captive Amazonian manatees (Trichechus inunguis). Vet Clin Pathol (2011) 0.75